4 results
The objective of this study is to explore the efficacy and safety of gevokizumab in patients with Schnitzler syndrome.
The objective of this study is to evaluate the effect of the 4 successive monthly subcutaneous administrations of 30 mg of gevokizumab (in part A) , as well as 60mg (in part B) of the protocol, versus placebo on the reduction of arterial wall…
The aim of this study is to investigate the use of spirometry, forced oscillation technique (FOT), and negative expiratory pressure (NEP) in both protrusion and retraction of the mandible as prediction measurements for MAD success.
To investigate the incidence of new-onset AF in patients with CAD and a single chamber ICD.